President

Chaoyang Dai, Ph. D.
Principal Scientist, Merck Research Laboratories, Cambridge, MA

Vice Presidents

Zhiyong Yang, Ph. D.
Principal Research Scientist, Pfizer Inc., Cambridge, MA

Qinglin Che, Ph. D.
Research Scientist, Syntha Pharmaceuticals, Inc., Lexington, MA

Zhihong Chen, Ph. D.
Sr. Research Investigator, Eisai Research Institute, Andover, MA

Sue Ma, M. D.
Investigator, Novartis Institute of BioMedical Research, Cambridge, MA

Executive Committee Members

Kevin Fang, Ph. D.
Director of Chemistry, Sepracor Inc., Marlborough, MA

Fred Hu, Ph. D.
Principal Research Scientist, Pfizer Inc., Cambridge, MA

Jia Huang, Ph. D.
Scientist, Allergan Inc., Cambridge, MA

Jinbo Lee, Ph. D.
President, Sage International Inc., Cambridge, MA

Shengfang Jin, Ph. D.
Director/Cell Biology, Agios Pharmaceuticals, Inc., Cambridge, MA

Fushuang Liu
Vice President, Wuxi Howfond Biopharma Co., Ltd., Wuxi, Jiangsu, China

Hanlan Liu, Ph. D./MBA
Director/DMPK, Genzyme Corporation, Framingham, MA

Haihong Ni, Ph. D.
Director of Computational Science, Chemizon, Beijing

Shallwei Sun
President, Callisyn Pharmaceuticals, Inc, Boston, MA

Ze Tian, Ph. D.
Investigator, Children’s Hospital Boston/Harvard Medical School, Boston, MA

Yongzhong Wang, Ph. D.
Staff Scientist, Genzyme Biosurgery/MTS, Cambridge, MA

Zhigang Wang, Ph. D.
Sr. Principal Scientist, Pfizer Research Technology Center, Cambridge, MA

Roger Xie, Ph. D.
Co-founder, EVP, Head of Global Development, China PharmaHub Corp., Cambridge, MA

Herong Yang, Ph. D.
Chief Architect, Open Channel Solutions, Boston, MA

Yongwen(Tony) Yuan
Cheminformatics Specialist, Novartis Institute of BioMedical Research, Cambridge, MA

Philip Zhang, Ph. D.
Special Counsel, Colley Godward Kronish LLP, Boston, MA

Weiyi(Wendy) Zhang, Ph. D.
President, Boston Lincoln International, Lincoln, MA

Liping Zhou, Ph. D.
Investigator, Novartis Institute of BioMedical Research, Cambridge, MA

Zhendong Zhu, Ph. D.
Principal Scientist, Pfizer Research Technology Center, Cambridge, MA

Board of Directors

Yihan Wang, Ph. D.; Chairman of the Board
Associate Director/Chemistry, ARIAD Pharmaceuticals, Inc., Cambridge, MA

Jun Han, Ph. D.; Founding President
Global R&D Project Manager, Teva Pharmaceuticals, Inc., Pomona, NY

Shiwen Lin, Ph. D.
Associate Director, Antigenics, Inc. Lexington, MA

Lixin Shen, Ph. D.
President and CEO, Wuxi Howfond Biopharma Co., Ltd., Wuxi, Jiangsu, China

Zhao-Kui Wan, Ph. D.; Immediate Past-President
Principal Research Scientist, Pfizer Inc., Cambridge, MA

Erxi Wu, Ph. D.
Investigator, Harvard-MIT HST Division, Boston, MA

Junjun Wu, Ph. D.; Past President
Principal Research Scientist, Pfizer Inc., Cambridge, MA

CABA Legal Council

Fred Gilman
Attorney at Law, Lynch, DeSimone & Nylen, LLP, Boston, MA

CABA Advisors

Tomi Sawyer, Ph. D.
Chief Scientific Officer and Senior Vice-President, Aileron Therapeutics, Cambridge, MA

Yibin Xiang, Ph. D.
Senior Director/Medicinal Chemistry, Genzyme Corporation, Cambridge, MA

Gangfeng Xu, Ph. D.
Sr. Director/Head of Asia & Pacific Business Development, Pfizer Inc., NY

Howard Yuwen, Ph. D.
Sr. Director, Shire Pharmaceuticals, Cambridge, MA

Chen Li, Ph. D.
Head of Research and Chief Scientific Officer, Roche R&D Center(China) Ltd.

Steve Yang, Ph. D.
Vice President and Head of Pfizer Asia R&D(Shanghai), Shanghai, China

Tim Clackson, Ph. D.
Sr. VP and Chief Scientific Officer, Ariad Pharmaceuticals Inc., Cambridge, MA

Youssef Bennani, Ph. D.
Vice President/Discovery Chemistry, Vertex Pharmaceuticals Inc., Cambridge, MA

Dawei Ma , Ph. D.
Professor, Shanghai Institute of Organic Chemistry, Shanghai, China

Roger Tung, Ph. D.
CEO and President, Concert Pharmaceuticals, Lexington, MA

Steve Projan, Ph. D.
Vice President, Global Head of Infectious Diseases, Novartis Institute of BioMedical Research, Cambridge, MA

John Piwinski, Ph. D.
Group VP and Site Head, Merck Research Laboratories, Cambridge, MA

Tarek Mansour, Ph. D.
VP and Head of Chemical Sciences, Wyeth Research Institute, Wyeth Pharmaceuticals

Liming Shao, Ph. D.
Senior Director/Medicinal Chemistry, Sepracor Inc., Marlborough, MA

Pierre Dodion, M. D., MBA
Sr. VP and Chief Medical Officer, Ariad Pharmaceuticals Inc., Cambridge, MA

Yuanli Liu, Ph. D.
Director of China Initiative, Sr. Lecturer on International Health, Dept. of Global Health and Population, Harvard School of Public Health

Shi Li, Ph. D.
Senior Director/Technology Development, Genzyme Corporation, Framingham, MA

Tse Ping
Chairman, Sino Biopharmaceutical Ltd., Beijing, China

Suvit Thaisrivongs, Ph. D.
Vice President, Pfizer, Inc., Cambridge. MA